|
Exosomal Drug Delivery
|
1R44CA221487-01
|
$719,680
|
|
GUPTA, RAMESH
|
3P BIOTECHNOLOGIES, INC.
|
|
A Circulating Biomarker for use in Monitoring Metastatic Breast Cancer
|
1R43CA210817-01A1
|
$152,589
|
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
Targeted Therapy for Non Small Cell Lung Carcinoma: Human Phase 1 safety and dose escalation studies
|
2R44CA162629-02A1
|
$1,154,726
|
|
SERRERO, GINETTE
|
A AND G PHARMACEUTICAL, INC.
|
|
AVGN7, a Novel Gene Therapeutic for Treating Cancer Cachexia
|
1R44CA221539-01
|
$1,206,955
|
|
RODGERS, BUEL
|
AAVOGEN, INC.
|
|
Novel Materials for Viral Purification
|
1R43CA217454-01A1
|
$224,166
|
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
Personalized precision dosing of biologic therapies in oncology
|
1R44CA217336-01A1
|
$759,813
|
|
MESSMER, BRADLEY
|
ABREOS BIOSCIENCES, INC.
|
|
Feasibility of predicting AML response to induction chemotherapy
|
1R43CA221473-01
|
$299,999
|
|
HENDERSON, PAUL
|
ACCELERATED MEDICAL DIAGNOSTICS, LLC
|
|
Magneto-electronic Sensing of Cancer in Urine
|
1R43CA221535-01
|
$220,000
|
|
SANG, LIYUN
|
ACCURE HEALTH, INC.
|
|
Therapeutic disruption of Connexin43-mediated microtubule regulation to target glioblastoma cancer stem cells
|
1R41CA217503-01
|
$224,999
|
|
LAMOUILLE, SAMY
|
ACOMHAL RESEARCH, INC.
|
|
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
|
3R41CA200161-01A1S2
|
$50,000
|
|
SONENSHEIN, GAIL
|
ADECTO PHARMACEUTICALS, INC.
|
|
Oral formulation for novel inhibitor of Ras driven cancers
|
1R43CA217502-01A1
|
$300,000
|
|
CANZONERI, JOSHUA
|
ADT PHARMACEUTICALS, LLC
|
|
Peptide-based tool for the rapid isolation of quiescent monocytes from peripheral blood
|
1R43CA211061-01A1
|
$308,839
|
|
DARBY, MARTYN
|
AFFINERGY, LLC
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
Distance Education to Engage Alaskan Community Health Aides in Cancer Control
|
5R25CA186882-04
|
$160,384
|
|
CUEVA, MELANY
|
ALASKA NATIVE TRIBAL HEALTH CONSORTIUM
|
|
Building Research Capacity to Address the Challenge of Non Communicable Diseases and Injuries in Rwanda The GUKORANA Research Center
|
1P20CA210284-01A1
|
$340,631
|
|
CASTLE, PHILIP
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The role of tunneling nanotubes as a novel mode of tumor cell-macrophage communication
|
5F99CA212451-02
|
$44,044
|
|
HANNA, SAMER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Training of Surgeons for Studies of the Tumor Microenvironment
|
5T32CA200561-03
|
$277,522
|
|
MICHLER, ROBERT
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
5F31CA183493-04
|
$49,044
|
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Molecular markers of risk of subsequent invasive breast cancer in women wth ductal carcinoma in situ
|
1R01CA218429-01
|
$1,513,571
|
|
ROHAN, THOMAS
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Contributions of sympathetic signals to prostate cancer progression.
|
5F30CA203446-02
|
$49,044
|
|
ZAHALKA, ALI
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Therapeutic TRPA1 Mechanism-Based Treatment of Chemotherapeutic-Induced Neuropathic Pain
|
1R43CA210759-01A1
|
$291,147
|
|
HERZ, JEFF
|
ALGOMEDIX, INC.
|
|
A NOVEL SMALL MOLECULE CX3CR1 ANTAGONIST HALTS METASTASIS
|
2R44CA183362-02A1
|
$822,075
|
|
SALVINO, JOSEPH
|
ALLIANCE DISCOVERY, INC.
|
|
Preparation of site-specific antibody-drug conjugates by proximity-based sortase ligation
|
1R41CA221374-01
|
$224,996
|
|
TSOURKAS, ANDREW
|
ALPHATHERA, INC.
|
|
Tenth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
|
1R13CA221309-01
|
$66,000
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Young Minority Scientists in the Field of Cancer
|
5R13CA040577-31
|
$69,443
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
MSI Faculty in the Field of Cancer Research
|
5R13CA076526-20
|
$69,443
|
|
FOTI, MARGARET
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Integrative Molecular Epidemiology Workshop
|
5R25CA174664-05
|
$249,213
|
|
SELLERS, THOMAS
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Colon cancer risk-stratification via optical analysis of rectal ultrastructure
|
5R44CA199667-02
|
$835,665
|
|
WALI, RAMESH
|
AMERICAN BIOOPTICS, LLC
|
|
The Political Economy of Tobacco Farming in Low-and Middle-Income Countries
|
R01TW010898-06
|
$172,820
|
|
Drope, Jeffrey
|
AMERICAN CANCER SOCIETY, INC.
|
|
Clinical Trial of ABC294640 in Patients with Refractory Multiple Myeloma
|
5R44CA199767-02
|
$659,861
|
$659,861
|
SMITH, CHARLES
|
APOGEE BIOTECHNOLOGY CORPORATION
|
|
Practical high resolution microscopy of un-cut, un-embedded lung biopsies
|
2R44CA189522-02
|
$1,091,279
|
|
LEVENE, MICHAEL
|
APPLIKATE TECHNOLOGIES, LLC
|
|
Development of a Pharmacoprotector for Platinum Toxicities
|
1R43CA206705-01A1
|
$225,000
|
|
CHIEN, HUAN-CHIEH
|
APRICITY THERAPEUTICS, INC.
|
|
Immunosignatures to Distinguish Breast Cancer Subtypes and Cancer Recurrence
|
1R21CA220150-01
|
$123,600
|
|
JOHNSTON, STEPHEN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Digital Stories Intervention on Psychosocial Well-being for Cancer Patients and Caregivers undergoing Hematopoietic Stem Cell Transplantation (HCT)
|
1R15CA213035-01A1
|
$484,697
|
|
KIM, WONSUN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Novel approaches to study immune responses to post translational modifications for cancer detection
|
5U01CA214201-02
|
$462,286
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Couple Communication in Cancer: A Multi-Method Examination
|
5R01CA201179-02
|
$650,269
|
|
LANGER, SHELBY
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-03S1
|
$129,167
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Proteasome inhibitors for the treatment of solid tumors
|
1R01CA213223-01A1
|
$381,450
|
|
KISSELEV, ALEXEI
|
AUBURN UNIVERSITY AT AUBURN
|
|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-14S1
|
$24,361
|
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
PTEN, Tregs and MDSCs in the tumor microenvironment
|
1R01CA211229-01A1
|
$347,700
|
|
MUNN, DAVID
|
AUGUSTA UNIVERSITY
|
|
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
|
7R01CA132115-08
|
$428,056
|
|
PESTELL, RICHARD
|
BARUCH S. BLUMBERG INSTITUTE
|
|
High Resolution High Throughput Proteomics Platform for Cancer Research
|
1R33CA217699-01
|
$410,858
|
|
IBRAHIM, YEHIA
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
PNNL Proteome Characterization Center
|
5U24CA210955-02
|
$1,091,415
|
|
LIU, TAO
|
BATTELLE PACIFIC NORTHWEST LABORATORIES
|
|
Consortium for large-scale production and phenotyping of knockout mice (UM1)
|
UM1HG006348-07
|
$1,260,000
|
|
BEAUDET, ARTHUR
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ9) Directed and unbiased studies of synaptic injuries as sequelae of radiotherapy: mapping, sex-dependence, and reversal
|
1R01CA219667-01
|
$554,770
|
|
DUMAN, JOSEPH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
1R21CA217137-01
|
$209,093
|
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
ALTERED MICROBIOME IN PANCREATITIS, DIABETES AND PANCREATIC CANCER
|
U01DK108326-03
|
$190,000
|
|
FISHER, WILLIAM
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQB-1) Telomere maintenance defects and thyroid second cancer in childhood cancer survivors
|
5R01CA194473-03
|
$347,361
|
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
2P50CA126752-11
|
$3,097,657
|
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
The role of DNMT3A in gene regulation and stem cell expansion
|
1F99CA222736-01
|
$45,544
|
|
HUANG, YUNG-HSIN
|
BAYLOR COLLEGE OF MEDICINE
|
Total relevant funding to Multiple Myeloma for this search: $61,036,038
|